boring region in the hippocampus, and are integrated into neural circuitry in destination [5, 6] . Recent studies have shown that neurons generated through neurogenesis in adulthood are involved in the neural functions of olfactory discrimination and trace memories in the olfactory bulb and hippocampus, respectively [7, 8] . Neurogenesis is a dynamic process that is regulated by environmental factors, extracellular signals, and intracellular signal transduction pathways. Based on several lines of evidence, epidermal growth factor (EGF) and related growth factors such as transforming growth factor-α (TGF-α) have been suggested to be involved in the regulation of NSC proliferation, a key step for neurogenesis, in the adult brain. First, intracerebroventricular administration of EGF stimulates NSC proliferation in the SVZ in mice and rats [9, 10] . Treatment of neu-rospheres with EGF alone or in combination with fibroblast growth factor-2 (FGF-2) stimulates proliferation of NSCs isolated from adult brains [11, 12] . Second, during aging, there is a correlational decrease among EGF receptor signaling in the SVZ, neurogenesis in the olfactory bulb, and olfactory discrimination [13] . Additionally, neurogenesis in the SVZ is decreased in genetically TGF-α-disrupted mice [14] .
Cyclic adenosine 3',5'-monophosphate (cAMP), one of major regulators of cell proliferation in a variety of cells, stimulates or inhibits cell proliferation in a protein kinase A (PKA) dependent manner [15] . Mitogenic signals related to the cAMP-PKA pathway are mediated predominantly by the transcription factor cAMP response element-binding protein (CREB) [16] . Defects in embryonic neurogenesis in CREB-disrupted mice clearly show the requirement of CREB for embryonic neurogenesis [17] . However, it is poorly understood whether and how CREB is involved in neurogenesis of the adult brain. Nakagawa et al. [18] reported that proliferation in the SGZ of the adult mouse hippocampus was increased by chronic administration of rolipram, an inhibitor of cAMP-specific phosphodiesterase, and was decreased in conditional transgenic mice that express MCREB, a dominant-negative CREB mutant, in the hippocampus. However, their immunohistochemical analysis revealed that, despite the fact that rolipram administration increased the number of phosphorylated CREB (pCREB)-immunoreactive cells in the SGZ, these pCREB-immunoreactive cells did not colocalize with proliferating cells, indicating the possibility that the cAMP-CREB pathway in surrounding cells regulates NSC proliferation via release of a mitogenic factor. In addition, administration of FGF-2, a mitogen comparable to EGF, stimulates CREB activation via Akt in NSCs of adult hippocampal SGZ while MCREB expression modestly suppresses FGF-2-stimulated proliferation of NSCs, suggesting that CREB partly mediates FGF-2-stimulated proliferation but is not a major mediator [19] .
Therefore, we investigated the role of CREB in the regulation of cell proliferation using NSCs isolated from the forebrain SVZ of adult mice. We show here that basal CREB activity is required for EGFstimulated proliferation of NSCs at a signaling level between extracellular signal-regulated kinase (ERK) activation and downstream serum response element (SRE)-mediated transcriptional activation.
AP-1-binding sequence, pAP1-Luc (Mercury Pathway Profiling System) was digested with BamHI and NotI. The resultant fragment containing the reporter gene was subcloned into a BamHI-and NotI-digested fragment of a pTRE-Shuttle2 vector lacking its tetracycline-responsive expression cassette, pTRE-Shuttle2-NruI.MCS.SmaI [22] . To normalize luciferase activity obtained by these reporter genes, we generated an adenovirus vector expressing the Renilla luciferase gene driven by a P Tal promoter lacking only the consensus sequences mentioned above (Ad-Tal/hrLuc) from the plasmids pTal-Luc (Mercury Pathway Profiling System) and phRL-null (Promega) as follows: The P Tal promoter excised from pTal-Luc by BamHI-and NotI-digestion was inserted into pTRE-Shuttle2-NruI. MCS.SmaI, whose firefly luciferase reporter gene was then exchanged by the Renilla luciferase gene at the NcoI and XbaI sites. DNA fragments were isolated from pTRE-Shuttle2-NruI.MCS.SmaI containing the reporter genes by digestion with I-CeuI and PI-SceI and inserted into a site created with the same restriction enzymes in Adeno-X viral DNA, a replicationincompetent adenoviral genome. The Adeno-X carrying the reporter gene was transfected into HEK293 cells using the FuGENE 6 transfection reagent (Roche Diagnostics) for virus production, and the recombinant adenoviruses were further propagated by serial infections in HEK293 cells. The adenoviruses obtained were purified with the Adeno-X Virus Purification Kit (Clontech Laboratories) and concentrated with the Centricon Centrifugal Filter Unit (Millipore, Bedford, MA). The titer of adenovirus vectors (infectious units, ifu) was determined using the Adeno-X Rapid Titer Kit (Clontech Laboratories). Ad-TRE/βgal and Ad-Tet.Off were purchased from Clontech Laboratories.
Immunostaining
To determine the BrdU-labeling index, NSCs were labeled with 200 µM 5-bromo-2'-deoxyuridine (BrdU) (Sigma Chemicals) for 2 h and fixed with ice-cold methanol for 30 min. Immunostaining for BrdU was carried out as described previously [23] with some modifications. To double-stain for BrdU and nuclei, the concentration of HCl was reduced to 2.2 N, and H33342 (Sigma Chemicals) was used at 5 µg/mL for 30 min. Immunostained dishes were covered with PermaFluor (Immunon, Pittsburgh, PA) and examined using a fluorescence microscope (BX50-FLA; Olympus, Tokyo, Japan). A total of five hundred H33342-stained NSCs cells were triturated for 10 min and plated at a cell density of 6.4x10 5 cells/dish in a 10-cm Hydrocell dish (Cellseed). Passages of neurospheres were repeated every 7-10 days. NSCs used for experiments were obtained from spheres with 2nd-9th passages.
For experiments, dissociated NSCs were plated at a cell density of 2x10 5 cells/dish on 35 mm culture dishes coated with poly-D-lysine and fibronectin (Becton Dickinson Biosciences). NSCs were cultured in monolayer with growth medium for 2 days, and then growth medium was changed to an experimental medium, DMEM/F12 containing 1 mg/mL BSA, 10 µg/mL transferrin, 40 nM sodium selenite, 100 µM putrescine, 30 µM ethanolamine, and 5 mM ethanol. EGF and forskolin (Sigma Chemicals) were used as mitogens at concentrations of 10 ng/mL and 10 µM, respectively. KT5720 and H89 were purchased from Biomol Research Laboratories (Plymouth Meeting, PA). U0126 was purchased from Promega (Madison, WI).
In some experiments using adenovirus vectors, NSCs were infected with adenoviruses on the day after plating. Cells were incubated with a minimal medium volume of 0.7 mL containing adenoviruses and rocked every hour for a total of 4 h. They were left for 1 day until growth medium containing adenoviruses was changed to the experimental medium.
Adenovirus vectors
Recombinant adenovirus vectors were produced using the Adeno-X Expression and Adeno-X Tet-Off Expression Systems according to the manufacturer's protocol (Clontech Laboratories, Mountain View, CA). To express MCREB [21] , an adenovirus carrying the Tet-responsive element-driven MCREB tagged at the N-terminus with 6×His (Ad-TRE/MCREB) was generated as described previously [22] . NSCs were infected with a combination of Ad-TRE/MCREB and Ad-Tet. Off, an adenovirus carrying the cytomegalovirus promoter-driven tetracycline-controlled transactivator gene tTA to express MCREB in the absence of tetracycline. An adenovirus vector expressing the firefly luciferase reporter gene driven by a TATA-like promoter (P Tal ) containing the consensus cAMP response element (CRE) or SRE sequence (Ad-CRE/Luc or Ad-SRE/Luc respectively) was produced from the plasmid (Mercury Pathway Profiling System, Clontech Laboratories) as described previously [22] . To produce an adenovirus vector expressing the luciferase gene driven by a P Tal promoter containing the consensus SDS, and electrotransferred to a polyvinylidene difluoride membrane (Hybond-P) (Amersham Biosciences, Piscataway, NJ). The membrane was treated with a blocking buffer containing 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween 20 (TBST) supplemented with 5% non-fat dry milk overnight at 4 ˚C, probed with an anti-phospho-p44/42 mitogen-activated protein kinase (Thr202/Tyr204) antibody (Cell Signaling Technology) at a 1:4,000 dilution or anti-ERK1 antibody (Becton Dickinson Biosciences, San Jose, CA) at a 1:1,000 dilution in TBST for 3 h at room temperature, and subsequently incubated with a secondary antibody conjugated to horseradish peroxidase (Amersham Biosciences) at a 1:10,000 dilution in TBST for 1 h. Signals were detected using the ECL plus Western Blotting Detection System (Amersham Biosciences) and a luminoimage analyzer (LAS-1000 plus, Fuji Film, Tokyo, Japan).
Luciferase assay
NSCs were lysed with 200 µL of Passive Lysis Buffer (Promega) and collected with a cell scraper according to the manufacturer's protocol. Twenty-microliter aliquots of the lysates were assayed for both firefly and Renilla luciferase activities using the Dual-Luciferase Reporter Assay System (Promega). Light intensity was measured with a luminometer (BLR-201, Aloka, Tokyo, Japan). The firefly luciferase activity obtained with a reporter adenovirus vector carrying a specific transcription factor-binding DNA sequence was normalized to the Renilla luciferase activity obtained with the control adenovirus vector Ad-Tal/hrLuc.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's protocol and treated with RNase-free DNase I (Qiagen). RNA (0.5 µg) was reverse-transcribed using oligo (dT)20 primer and ReverTra Ace reverse transcriptase (Toyobo, Osaka, Japan). Reverse transcriptase reactions were amplified on an ABI Prism 7500 Sequence Detection System (Applied Biosystems, Foster City, CA) using a SYBR Green Realtime PCR Kit (Toyobo). The primers used are shown in Table 1 . The final PCR products were subjected to thermal denaturation to ensure that the product denatured as a uniform peak. mRNA levels were calculated by the 2 -∆∆CT method using glyceraldehyde-3-phosphate dehydrogewere examined in randomly chosen fields for each dish to determine the percentage of BrdU-immunoreactive cells in the total NSCs counted.
To verify that the used cells were NSCs, the cells were fixed after the experiments with 3% paraformaldehyde for 10 min. The cells were treated with 1% Tween 20 for 30 min, 3% hydrogen peroxide for 10 min, 0.5% blocking reagent supplied in the TSA Fluorescence System (NEL701A; PerkinElmer, Boston, MA) for 30 min, and then immunostained for the RNA-binding protein Musashi1, an immature neural progenitor cell marker with 1) a rat anti-Musashi1 antibody (clone 14H1, provided by Dr. H. Okano, Keio University) at a 1:1,000 dilution overnight at 4 ˚C, 2) a goat biotinylated anti-rat IgG (Vector, Burlingame, CA) at a 1:200 dilution for 1 h, and 3) Texas Red-labeled streptavidin (Amersham Biosciences, Piscataway, NJ) at a 1:50 dilution for 1 h. Fluorescence images of the immunostained NSCs were captured with a digital CCD camera (DP50, Olympus) and stored on a personal computer.
To validate the adenovirus-mediated expression of 6×His-tagged MCREB protein, paraformaldehydefixed NSCs were treated with 1% Tween 20 for 30 min, 3% hydrogen peroxide for 10 min, 0.5% blocking reagent for 30 min, and then immunostained for 6×His tag with 1) a rabbit anti-His-Tag antibody (Cell Signaling Technology, Beverly, MA) at a 1:5,000 dilution for 150 min, 2) a peroxidase-labeled polymer reagent (Envision+; Dako Japan, Tokyo, Japan) for 1 h, and 3) FITC-labeled tyramide (PerkinElmer) at a 1:50 dilution for 10 min.
Western blot analysis
Cells were washed with PBS and harvested with cell lysis buffer containing 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 25 mM NaF, 50 mM β-glycerophosphate, 2 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail (Santa Cruz Biotechnology, Santa Cruz, CA). The cell lysates were placed on ice for 30 min and centrifuged at 18,000 × g for 15 min at 4 ˚C. Protein concentrations were quantified, and equal amounts of protein from each sample were boiled for 5 min in sample buffer containing 62.5 mM Tris-HCl, pH6.8, 2% SDS, 5% glycerol, 2.5% β-mercaptoethanol, and 0.1% bromophenol blue (Santa Cruz Biotechnology), separated on a 12.5% SDS-PAGE gel in electrophoresis buffer containing 25 mM Tris-HCl, 192 mM glycine, and 0.1% EGF-stimulated proliferation by 32% (p<0.05). When NSCs were treated with KT5720, proliferation was not changed at 1 µM but significantly inhibited at 5 µM by 92%, a more potent effect than seen with H89 (p<0.05). These results suggest that PKA activity is required for the mitogenic action of EGF in NSCs.
To determine whether CREB mediates the activity of the cAMP-PKA pathway required for NSC proliferation, we measured the effect of adenoviral expression of MCREB, a dominant negative mutant of CREB, on EGF-stimulated proliferation. Ad-TRE/MCREB, an nase (GAPDH) as an endogenous reference.
Statistical analysis
Experiments were carried out using three culture dishes per experimental group and replicated at least three times with separate batches of cell preparations. Differences between groups were statistically analyzed using one-way ANOVA followed by TukeyKramer tests.
results

Basal activity of the cAMP-PKA-CREB pathway is required for EGF-stimulated NSC proliferation
At the end of the experiments, the cultured cells were verified to be NSCs by immunocytochemistry. Most of the cultured cells (86-93%) were immunoreactive for the RNA-binding protein Musashi1 [24] (Fig. 1) .
To determine whether the cAMP-PKA pathway is involved in the regulation of proliferation of adult SVZ NSCs, we investigated the effect of H89 and KT5720, specific PKA inhibitors [25, 26] , on the mitogenic action of EGF. NSCs were cultured in monolayer in growth medium containing B27, FGF-2, and EGF for 2 days after plating. Twenty four hours after the growth medium was changed to an experimental medium without these growth factors, NSCs were treated with 10 ng/mL EGF in combination with either vehicle, H89, or KT5720 for 24 h. NSCs treated with vehicle exhibited a high level of proliferation as determined by BrdU-labeling (Fig. 2) . Treatment with H89 at 10 µM, but not 2 µM, significantly inhibited Off lacked 6×His-immunoreactivity (Fig. 3A) . This verified a specific expression of MCREB by the adenovirus-mediated Tet-Off system in the absence of tetracycline. Infection of EGF-stimulated NSCs with adenovirus vectors, such as Ad-TRE/MCREB or Ad-Tet. Off alone, or a combination of Ad-TRE/βgal and Ad-Tet.Off, decreased cell proliferation to some degree as compared with uninfected NSCs (p<0.05) (Fig. 3B) . However, MCREB expression by combinational infecadenovirus vector carrying the Tet-responsive elementdriven gene for 6×His-tagged MCREB, or Ad-TRE/ βgal, an adenovirus vector carrying the Tet-responsive element-driven β-galactosidase gene, was infected in combination with Ad-Tet.Off, an adenovirus vector expressing a tetracycline-controlled transactivator gene, at 10 MOI each to express MCREB or β-galactosidase (as a control), respectively, in NSCs. Immunostaining for the tag 6×His revealed that only NSCs infected with a combination of Ad-TRE/MCREB and Ad-Tet. Off showed nuclear 6×His-immunoreactivity whereas CREB affect basal and EGF-stimulated proliferation of NSCs. Treatment with 10 µM forskolin alone had no effect on cell proliferation in the absence of EGF (Fig.  4B ). In comparison, increasing concentrations of EGF were highly effective in stimulating proliferation with a plateau at 1 ng/mL (p<0.05). However, simultaneous treatment of EGF-stimulated NSCs with forskolin did not affect proliferation stimulated by any EGF concentration. These results demonstrate that an increase in intracellular cAMP concentration or subsequent CREB activation affect neither basal nor EGF-stimulated NSC proliferation.
Blockade of CREB activity does not affect EGFinduced activation of ERK 1/2
Since it has been shown that EGF activates ERK 1/2 and stimulates cell proliferation [30] , we examined whether blockade of ERK 1/2 activation inhibits EGF-stimulated proliferation of NSCs. Treatment with U0126, an inhibitor of MEK which directly activates ERK 1/2 [31] , did not affect EGF-stimulated proliferation at 1 µM but significantly inhibited it at 5 µM (p<0.05) (Fig. 5A) , suggesting ERK 1/2 as a key protein kinase mediating EGF-regulated mitogenic signaling. To address the possibility that inhibition of the cAMP-PKA-CREB pathway blocks EGF-stimulated NSC proliferation by inhibiting ERK 1/2 activation, tion with Ad-TRE/MCREB and Ad-Tet.Off markedly inhibited NSC proliferation as compared with combinational infection with Ad-TRE/βgal and Ad-Tet. Off (p<0.05). Furthermore, the inhibition of EGFstimulated NSC proliferation by MCREB expression was Ad-TRE/MCREB dose-dependent (Fig. 3C) .
Because it has been shown that EGF activates CREB through a PKA-dependent or independent mechanism in other cell types [27] [28] [29] , our results raised the question of whether EGF activates CREB to stimulate NSC proliferation. Therefore, we determined the transcriptional activity of a cAMP-response element (CRE)-regulated reporter gene in EGF-treated NSCs. NSCs were infected with Ad-CRE/Luc, an adenovirus vector carrying the CRE-regulated luciferase reporter gene. EGF treatment was not effective at 1 h but significantly increased luciferase reporter activity at 2 and 4 h (p<0.05) 1.8-and 2.3-fold, respectively (Fig.  4A) . In contrast, forskolin, an adenylate cyclase activator, given as a positive control at 10 µM, increased luciferase reporter activity approximately 60-fold by as early as 1 h and further increased it up to 4 h (p<0.05). These results demonstrate that, in NSCs, EGF causes a moderate increase in CREB activity that is much less than that induced by forskolin.
We next asked whether the increase in intracellular cAMP concentration and the subsequent activation of eration-related immediately early genes (IEGs) through ERK activation [32, 33] raised the possibility that basal CREB activity is required for EGF-stimulated NSC proliferation at a level of ERK-stimulated expression of IEGs. We chose a set of IEGs whose expression is stimulated by EGF treatment in mouse NSCs and determined their expression by measuring mRNA levels by qRT-PCR. In control β-galactosidase-expressed NSCs, EGF treatment significantly increased expression levels of c-fos, c-jun, and jun-B with a peak at 30 min, those of fra-1 and c-myc with a peak at 2 h, and those of c-myb with a peak at 4 h (p<0.05) (Fig.  6A ). Viral MCREB expression exerted gene-specific influences on basal and EGF-stimulated expression. MCREB expression significantly increased basal levels of gene expression of c-myc, c-jun, and fra-1 to 2.4, 2.2, and 3.6-fold levels (p<0.05) but not those of c-fos and jun-B. In particular, basal levels of c-myb expression were increased by MCREB expression as much we determined whether EGF activation of ERK 1/2 is inhibited by PKA inhibitors using Western blot analysis. Treatment with EGF markedly increased levels of pERK1/2 at 1 and 3 h in NSCs deprived of EGF for 24 h (Fig. 5B) . Pretreatment with 10 µM H89 or 5 µM KT5720 1 h prior to EGF treatment did not affect EGFstimulated pERK levels at either 1 or 3 h. These results suggest that the EGF signaling pathway upstream of ERK activation is not inhibited by PKA inhibitors in NSCs. We next examined the effect of MCREB expression on EGF activation of ERK 1/2. Similarly to PKA inhibitors, viral expression of neither β-galactosidase nor MCREB affected EGF-stimulated pERK levels at 1 and 3 h (Fig. 5C ).
Basal CREB activity is required for EGF-induced immediately early gene expression and SRE-mediated transcriptional activation
The fact that EGF stimulates the expression of prolif- novirus-mediated expression of MCREB had a similar effect on NSC proliferation. However, it should be noted that the effects of MCREB found in the present study could be partly due to blockade of transcriptional activities of other CREB family members, such as CRE modulator and activating transcription factor 1, because the consensus CRE sequence to which MCREB binds is also a site targeted by these CREB family members [36, 37] . Growth factors have been known to activate CREB in PKA-dependent and independent manners. EGF activates adenylate cyclase [38, 39] and inhibits cAMPspecific phosphodiesterase [28] , leading to high intracellular cAMP levels and subsequent PKA activation. In addition, EGF activates ribosomal S6 kinase 2 [29] and mitogen-and stress-activated protein kinase 1 [40] , which in turn directly activate CREB as does PKA. Indeed, EGF activates CREB in cultured adult NSCs of the SVZ [41] . Consistent with these findings, we observed that EGF treatment induced an increase in CRE-mediated transcriptional activity in NSCs. Based on these findings, it was possible that EGF activates CREB, thereby stimulating NSC proliferation. However, taken together with the result that forskolin, which was much more potent than EGF in stimulating CRE-mediated transcriptional activity, failed to affect basal or EGF-stimulated proliferation of NSCs, it seems unlikely that the observed EGF activation of CREB contributes to the mitogenic signal of EGF. Thus, it is suggested that the basal, but not EGF-stimulated activity of the cAMP-PKA-CREB pathway is required for EGF-stimulated NSC proliferation.
cAMP is well known to be an important regulator of cell proliferation in a variety of cells [15] . However, the present study has shown that activation of the cAMP-PKA pathway by forskolin affected neither basal nor EGF-stimulated proliferation of NSCs in the SVZ of adult mice following 24 h treatment. Our results are consistent with the finding that increased intracellular cAMP levels for 2 weeks, but not 24 h, stimulated proliferation in vivo in the SGZ of the adult mouse hippocampus [18] . It will be of interest to investigate the differential effects of long-versus short-term treatment with forskolin on NSC proliferation in future.
Inhibitors of MEK, an ERK1/2 kinase, were reported to block EGF-induced cell proliferation in NSCs [42] , which was confirmed in the present studies using U0126. These findings indicate that EGF stimulates proliferation at least in part through the activation of as 40-fold or more. Although EGF-stimulated c-myc expression was not affected by MCREB, expression of other genes including c-fos, c-jun, jun-B, and fra-1 was significantly inhibited at their peak expression times (p<0.05). To verify the consequences of these changes of IEG expression on transcriptional activity, we measured AP-1 transcriptional activity, which is caused by DNA binding of heterodimers of the Fos, Jun, and ATF family of transcription factors [34] . NSCs were infected with Ad-AP1/Luc, an adenovirus vector carrying the AP-1-regulated luciferase reporter gene. EGF treatment significantly increased AP-1-regulated luciferase activity at 3 h in control β-galactosidaseexpressed NSCs (p<0.05) (Fig. 6B, left panel) . In contrast, in MCREB-expressed NSCs, basal levels of AP-1-regulated luciferase activity were inhibited, and there was no increase in luciferase activity after EGF treatment.
ERK-stimulated IEG expression in NSCs may be mediated by Elk-1 phosphorylation and the subsequent formation of a ternary transcription complex of Elk-1 and SRF over the SRE sequence located in the promoter region of IEGs [35] . To examine whether basal activity of CREB is required for EGF-stimulated SRE activation, we measured SRE-mediated transcriptional activity in MCREB-expressed NSCs using Ad-SRE/ Luc, an adenovirus vector carrying the SRE-regulated luciferase reporter gene. EGF treatment significantly increased SRE-regulated luciferase activity 6.2-fold at 3 h in control β-galactosidase-expressed NSCs (p<0.05) (Fig. 6B, right panel) . In MCREB-expressed NSCs, basal levels of SRE-regulated luciferase activity were inhibited to 33%, and there was a small 1.7-fold increase in luciferase activity after EGF treatment. In addition, we investigated whether PKA inhibitor treatment suppresses SRE-mediated transcriptional activity as does MCREB expression. SRE-regulated luciferase activity after EGF treatment was significantly inhibited to 66% and 79% by 10 µM H89 and 5 µM KT5720, respectively (p<0.05) (Fig. 6C) .
Discussion
The present study showed that treatment with the PKA inhibitors H89 and KT5720 was highly effective in inhibiting EGF-stimulated NSC proliferation, suggesting that the activity of the cAMP-PKA pathway is required for mediating the mitogenic signal of EGF. This view is further supported by the result that ade-EGF-induced proliferation. The present study showed that PKA inhibitors suppressed EGF stimulation of SRE-mediated transcriptional activity, but the degree of SRE suppression by PKA inhibitors was less than that by MCREB expression. These results suggest that the action of PKA is mediated not only by CREB and SRE-dependent transcription but also by other proliferation-regulating molecules such as Akt.
In conclusion, we have shown that CREB is involved in EGF-stimulated proliferation of NSCs from the adult SVZ. Our results suggest that basal CREB activity is involved in the ERK-mediated EGF signaling pathway downstream, but not upstream, of ERK activation. The possible ERK-downstream step of CREB involvement may lie in SRE-mediated transcriptional activation of IEGs.
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ERK. Therefore, it is possible that basal CREB activity is involved at a step in the EGF-ERK signaling pathway in NSCs. The results in the present study that MCREB failed to inhibit ERK1/2 phosphorylation induced by EGF in NSCs suggest that basal CREB activity is not involved in the EGF signaling pathway upstream of ERK activation. EGF-activated ERK phosphorylates the transcription factor Elk-1 resulting in formation of a ternary transcription factor complex of Elk-1 and SRF over the cis-acting SRE in the promoter region of IEGs [35] . These findings raises the possibility that CREB is required in a signaling step between ERK phosphorylation and IEG expression for the regulation of EGFstimulated NSC proliferation. Indeed, this was supported by the results of the present study that MCREB blocked EGF stimulation of c-fos, c-jun, jun-B, and fra-1 expression and subsequent AP-1 transcriptional activation in NSCs. We have also shown that MCREB suppresses EGF stimulation of SRE-mediated transcriptional activity. These results are the first to suggest that the SRE existing in the c-fos promoter may be a target of MCREB. It remains to be determined precisely how MCREB inhibits EGF-induced SRE activation. On the other hand, it seems unlikely that the action of PKA on EGF-induced NSC proliferation is solely mediated by CREB even though PKA and CREB are required for references
